FR2527928B1 - Procede de preparation d'anticorps monoclonaux conjugues avec un chelate metallique et solution les contenant - Google Patents

Procede de preparation d'anticorps monoclonaux conjugues avec un chelate metallique et solution les contenant

Info

Publication number
FR2527928B1
FR2527928B1 FR8309437A FR8309437A FR2527928B1 FR 2527928 B1 FR2527928 B1 FR 2527928B1 FR 8309437 A FR8309437 A FR 8309437A FR 8309437 A FR8309437 A FR 8309437A FR 2527928 B1 FR2527928 B1 FR 2527928B1
Authority
FR
France
Prior art keywords
preparation
solution containing
monoclonal antibodies
metal chelate
antibodies conjugated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8309437A
Other languages
English (en)
French (fr)
Other versions
FR2527928A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/386,110 external-priority patent/US4472509A/en
Priority claimed from US06/386,109 external-priority patent/US4454106A/en
Application filed by Individual filed Critical Individual
Publication of FR2527928A1 publication Critical patent/FR2527928A1/fr
Application granted granted Critical
Publication of FR2527928B1 publication Critical patent/FR2527928B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015—Breast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Radiation-Therapy Devices (AREA)
FR8309437A 1982-06-07 1983-06-07 Procede de preparation d'anticorps monoclonaux conjugues avec un chelate metallique et solution les contenant Expired FR2527928B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/386,110 US4472509A (en) 1982-06-07 1982-06-07 Metal chelate conjugated monoclonal antibodies
US06/386,109 US4454106A (en) 1982-06-07 1982-06-07 Use of metal chelate conjugated monoclonal antibodies

Publications (2)

Publication Number Publication Date
FR2527928A1 FR2527928A1 (fr) 1983-12-09
FR2527928B1 true FR2527928B1 (fr) 1989-09-22

Family

ID=27011278

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8309437A Expired FR2527928B1 (fr) 1982-06-07 1983-06-07 Procede de preparation d'anticorps monoclonaux conjugues avec un chelate metallique et solution les contenant

Country Status (5)

Country Link
JP (1) JP2599705B2 (enrdf_load_stackoverflow)
CA (1) CA1225930A (enrdf_load_stackoverflow)
DE (1) DE3320560A1 (enrdf_load_stackoverflow)
FR (1) FR2527928B1 (enrdf_load_stackoverflow)
GB (1) GB2122641B (enrdf_load_stackoverflow)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707352A (en) * 1984-01-30 1987-11-17 Enzo Biochem, Inc. Method of radioactively labeling diagnostic and therapeutic agents containing a chelating group
CA1260827A (en) * 1984-08-31 1989-09-26 Richard C. Siegel Antibody-metal ion complexes
US5393512A (en) * 1985-01-14 1995-02-28 Vanderheyden; Jean-Luc Stable therapeutic radionuclide compositions and methods for preparation thereof
US4824986A (en) * 1985-04-26 1989-04-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Metal chelate protein conjugate
DE3786000T3 (de) * 1986-08-18 1997-08-21 Dow Chemical Co Conjugate dichter Sterne.
AU619218B2 (en) * 1987-11-06 1992-01-23 Abbott Laboratories Methods and materials for the preparation of metal labelled antibody solutions
JPH01176000A (ja) * 1987-12-30 1989-07-12 Nippon Mejifuijitsukusu Kk 放射性医薬品とその調製用高分子化合物
US5639624A (en) * 1989-03-14 1997-06-17 Board Of Regents Of The University Of Nebraska Monoclonal antibodies specific for metallic cations and method therefor
US5972656A (en) * 1989-03-14 1999-10-26 Bionebraska, Inc. Mercury binding polypeptides and nucleotides coding therefore
JPH05502219A (ja) * 1989-09-22 1993-04-22 ネオルクス　コーポレイション 安定な治療用放射性核種およびそれを調製する方法
US5244816A (en) * 1989-10-11 1993-09-14 Akzo N.V. Method for purifying chelator conjugated compounds
CA2100709C (en) * 1992-07-27 2004-03-16 Maurits W. Geerlings Method and means for site directed therapy
US6111079A (en) * 1995-06-05 2000-08-29 Bionebraska, Inc. Lead binding polypeptides and nucleotides coding therefore
EP0842668B1 (en) * 1996-11-15 2002-09-04 European Atomic Energy Community (Euratom) Ex-corpore method for treating human blood cells

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH583036A5 (enrdf_load_stackoverflow) * 1972-05-12 1976-12-31 Hoffmann La Roche
JPS5857149B2 (ja) * 1975-12-25 1983-12-19 スギウラ マモル エル − アミノサンサンカコウソノセイセイホウ
US4311688A (en) * 1979-10-29 1982-01-19 Serono Laboratories Inc. Composition and method for cancer detection in humans
US4421735A (en) * 1980-04-17 1983-12-20 The Massachusetts General Hospital Radiolabeled diagnostic compositions and method for making the same
NL8204108A (nl) * 1981-10-27 1983-05-16 Hybritech Inc In beeld brengen van tumor met radioactief gemerkte monoclonale antilichamen.
US4666697A (en) * 1982-12-08 1987-05-19 Nihon Medi-Physics Co., Ltd. Radioactive diagnostic agent

Also Published As

Publication number Publication date
GB8315483D0 (en) 1983-07-13
GB2122641B (en) 1986-08-06
JP2599705B2 (ja) 1997-04-16
DE3320560C2 (enrdf_load_stackoverflow) 1993-09-16
FR2527928A1 (fr) 1983-12-09
CA1225930A (en) 1987-08-25
DE3320560A1 (de) 1984-02-09
GB2122641A (en) 1984-01-18
JPS5946227A (ja) 1984-03-15

Similar Documents

Publication Publication Date Title
FR2522679B1 (fr) Procede pour la production d'anticorps monoclonaux humains
FR2502141B1 (fr) Procede de jonction d'un metal a du graphite
RO79840A (ro) Procedeu de prepararea unor granule stabilizate continind azotat de amoniu
FR2527928B1 (fr) Procede de preparation d'anticorps monoclonaux conjugues avec un chelate metallique et solution les contenant
FR2505312B1 (fr) Procede pour la preparation d'hydrure de potassium avec addition de metaux alcalins et de catalyseur
PT75499B (fr) Procede pour la preparation de l'alkanoilanilides
RO75967A (ro) Inel de ureche pentru animale
FR2493346B1 (fr) Procede de preparation d'un alliage magnetique amorphe
BE862106A (fr) Procede de preparation d'electro-corindon fondu
ES514537A0 (es) "metodo industrial de fijar cierres de cremallera a generos de punto".
PT75209B (fr) Procede de preparation d'amidobenzamides
BE896977A (fr) Procede perfectionne de depot anelectrolytique de l'or
FR2510804B1 (fr) Procede de preparation d'un oxyde de fer ferromagnetique contenant du cobalt
BE877999R (fr) Procede pour l'electrodeposition d'alliage fer-nickel
IT8249207A0 (it) Procedimento per l'arricchimento disolfuri metallici e composizione diraccolta impiegata
FR2503713B1 (fr) 2,3-di-substitue-5,6-dihydro-imidazo-(2,1-b) thiazoles, procede pour leur preparation et agents anti-inflammatoires les contenant
FR2476641B1 (fr) Procede de preparation d'amines secondaires
FR2501238B1 (fr) Procede d'elaboration d'un metal en fusion consistant principalement en manganese et en fer
ES512000A0 (es) "un metodo de fabricar un cuerpo refractario".
PT77767B (fr) Procede de preparation de 3',5'-diarabinosides et de compositi-ons pharmaceutiques les contenant
RO87007A (ro) Procedeu si instalatie pentru prepararea izomerozei
OA06787A (fr) Procédé d'enrichissement des minerais phosphatés.
EP0207170A4 (en) Process for preparing human cancer-specific monoclonal antibody.
FR2498056B2 (fr) Procede pour la preparation d'un extrait de champignons et extrait de champignons ainsi prepare
FR2499368B1 (fr) Procede de preparation de compositions a base d'olives et compositions obtenues

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse